The global Targeted Drug Delivery Device market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Targeted Drug Delivery Device is a method of delivery medication in some parts of the body. This means of delivery is largely founded on nanomedicine, which plans to employ nanoparticle-mediated drug delivery in order to combat the downfalls of conventional drug delivery. These nanoparticles would be loaded with drugs and targeted to specific parts where there is solely diseased tissue, thereby avoiding interaction with healthy tissue. The goal of the Targeted Drug Delivery is to prolong, localize, target and have a protected drug interaction with the diseased tissue. The conventional drug delivery system is the absorption of the drug across a biological membrane, whereas the targeted release system releases the drug in a dosage form. The advantages to the targeted release system is the reduction in the frequency of the dosages taken by the patient, having a more uniform effect of the drug, reduction of drug side-effects, and reduced fluctuation in circulating drug levels. The disadvantage of the system is high cost, which makes productivity more difficult and the reduced ability to adjust the dosages. (Wikipedia)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The publisher report includes an overview of the development of the Targeted Drug Delivery Device industry chain, the market status of Metabolic Disorder (Eye, Brain), Ophthalmic Disease (Eye, Brain), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Targeted Drug Delivery Device.
Regionally, the report analyzes the Targeted Drug Delivery Device markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Targeted Drug Delivery Device market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Targeted Drug Delivery Device market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Targeted Drug Delivery Device industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Eye, Brain).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Targeted Drug Delivery Device market.
Regional Analysis: The report involves examining the Targeted Drug Delivery Device market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Targeted Drug Delivery Device market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Targeted Drug Delivery Device:
Company Analysis: Report covers individual Targeted Drug Delivery Device players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Targeted Drug Delivery Device This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Metabolic Disorder, Ophthalmic Disease).
Technology Analysis: Report covers specific technologies relevant to Targeted Drug Delivery Device. It assesses the current state, advancements, and potential future developments in Targeted Drug Delivery Device areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Targeted Drug Delivery Device market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Targeted Drug Delivery Device market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
by Target Organ
Eye
Brain
Heart
Breast
Abdomen
Others
by Type of Biologic Delivered
Cell
Protein
Enzyme
Plasmid
Antibody
Small Peptide
Modified RNA
Growth Factor
Neurotransmitter
by Therapy Delivered
Cell Therapy
RNA Therapy
Gene Therapy
Immunotherapy
Stem Cell Therapy
麻豆原创 segment by Application
Metabolic Disorder
Ophthalmic Disease
Oncological Disorder
Neurological Disorder
Cardiovascular Disorder
Others
麻豆原创 segment by players, this report covers
4D Molecular Therapeutics
AbbVie
Abeona Therapeutics
Advaxis
Alcyone Lifesciences
AlphaVax
Amgen
Amicus Therapeutics
Anaeropharma Science
AnGes
AskBio
Astellas Pharma
AstraZeneca
Athersys
BioCardia
Biogen
BioInvent
BioRestorative Therapies
bluebird bio
Boston Scientific
CellProthera
Celsion
Celyad
Evonik
Kadimastem
Medtronic
Novartis
Sanofi
SOTIO
Takeda
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Targeted Drug Delivery Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Targeted Drug Delivery Device, with revenue, gross margin and global market share of Targeted Drug Delivery Device from 2019 to 2024.
Chapter 3, the Targeted Drug Delivery Device competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Targeted Drug Delivery Device market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Targeted Drug Delivery Device.
Chapter 13, to describe Targeted Drug Delivery Device research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Targeted Drug Delivery Device
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Targeted Drug Delivery Device by Type
1.3.1 Overview: Global Targeted Drug Delivery Device 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Targeted Drug Delivery Device Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Eye
1.3.4 Brain
1.3.5 Heart
1.3.6 Breast
1.3.7 Abdomen
1.3.8 Others
1.4 Global Targeted Drug Delivery Device 麻豆原创 by Application
1.4.1 Overview: Global Targeted Drug Delivery Device 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Metabolic Disorder
1.4.3 Ophthalmic Disease
1.4.4 Oncological Disorder
1.4.5 Neurological Disorder
1.4.6 Cardiovascular Disorder
1.4.7 Others
1.5 Global Targeted Drug Delivery Device 麻豆原创 Size & Forecast
1.6 Global Targeted Drug Delivery Device 麻豆原创 Size and Forecast by Region
1.6.1 Global Targeted Drug Delivery Device 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Targeted Drug Delivery Device 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Targeted Drug Delivery Device 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Targeted Drug Delivery Device 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Targeted Drug Delivery Device 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Targeted Drug Delivery Device 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Targeted Drug Delivery Device 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 4D Molecular Therapeutics
2.1.1 4D Molecular Therapeutics Details
2.1.2 4D Molecular Therapeutics Major Business
2.1.3 4D Molecular Therapeutics Targeted Drug Delivery Device Product and Solutions
2.1.4 4D Molecular Therapeutics Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 4D Molecular Therapeutics Recent Developments and Future Plans
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Targeted Drug Delivery Device Product and Solutions
2.2.4 AbbVie Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 AbbVie Recent Developments and Future Plans
2.3 Abeona Therapeutics
2.3.1 Abeona Therapeutics Details
2.3.2 Abeona Therapeutics Major Business
2.3.3 Abeona Therapeutics Targeted Drug Delivery Device Product and Solutions
2.3.4 Abeona Therapeutics Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Abeona Therapeutics Recent Developments and Future Plans
2.4 Advaxis
2.4.1 Advaxis Details
2.4.2 Advaxis Major Business
2.4.3 Advaxis Targeted Drug Delivery Device Product and Solutions
2.4.4 Advaxis Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Advaxis Recent Developments and Future Plans
2.5 Alcyone Lifesciences
2.5.1 Alcyone Lifesciences Details
2.5.2 Alcyone Lifesciences Major Business
2.5.3 Alcyone Lifesciences Targeted Drug Delivery Device Product and Solutions
2.5.4 Alcyone Lifesciences Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Alcyone Lifesciences Recent Developments and Future Plans
2.6 AlphaVax
2.6.1 AlphaVax Details
2.6.2 AlphaVax Major Business
2.6.3 AlphaVax Targeted Drug Delivery Device Product and Solutions
2.6.4 AlphaVax Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 AlphaVax Recent Developments and Future Plans
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business
2.7.3 Amgen Targeted Drug Delivery Device Product and Solutions
2.7.4 Amgen Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Amgen Recent Developments and Future Plans
2.8 Amicus Therapeutics
2.8.1 Amicus Therapeutics Details
2.8.2 Amicus Therapeutics Major Business
2.8.3 Amicus Therapeutics Targeted Drug Delivery Device Product and Solutions
2.8.4 Amicus Therapeutics Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Amicus Therapeutics Recent Developments and Future Plans
2.9 Anaeropharma Science
2.9.1 Anaeropharma Science Details
2.9.2 Anaeropharma Science Major Business
2.9.3 Anaeropharma Science Targeted Drug Delivery Device Product and Solutions
2.9.4 Anaeropharma Science Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Anaeropharma Science Recent Developments and Future Plans
2.10 AnGes
2.10.1 AnGes Details
2.10.2 AnGes Major Business
2.10.3 AnGes Targeted Drug Delivery Device Product and Solutions
2.10.4 AnGes Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 AnGes Recent Developments and Future Plans
2.11 AskBio
2.11.1 AskBio Details
2.11.2 AskBio Major Business
2.11.3 AskBio Targeted Drug Delivery Device Product and Solutions
2.11.4 AskBio Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 AskBio Recent Developments and Future Plans
2.12 Astellas Pharma
2.12.1 Astellas Pharma Details
2.12.2 Astellas Pharma Major Business
2.12.3 Astellas Pharma Targeted Drug Delivery Device Product and Solutions
2.12.4 Astellas Pharma Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Astellas Pharma Recent Developments and Future Plans
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business
2.13.3 AstraZeneca Targeted Drug Delivery Device Product and Solutions
2.13.4 AstraZeneca Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 AstraZeneca Recent Developments and Future Plans
2.14 Athersys
2.14.1 Athersys Details
2.14.2 Athersys Major Business
2.14.3 Athersys Targeted Drug Delivery Device Product and Solutions
2.14.4 Athersys Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Athersys Recent Developments and Future Plans
2.15 BioCardia
2.15.1 BioCardia Details
2.15.2 BioCardia Major Business
2.15.3 BioCardia Targeted Drug Delivery Device Product and Solutions
2.15.4 BioCardia Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 BioCardia Recent Developments and Future Plans
2.16 Biogen
2.16.1 Biogen Details
2.16.2 Biogen Major Business
2.16.3 Biogen Targeted Drug Delivery Device Product and Solutions
2.16.4 Biogen Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 Biogen Recent Developments and Future Plans
2.17 BioInvent
2.17.1 BioInvent Details
2.17.2 BioInvent Major Business
2.17.3 BioInvent Targeted Drug Delivery Device Product and Solutions
2.17.4 BioInvent Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 BioInvent Recent Developments and Future Plans
2.18 BioRestorative Therapies
2.18.1 BioRestorative Therapies Details
2.18.2 BioRestorative Therapies Major Business
2.18.3 BioRestorative Therapies Targeted Drug Delivery Device Product and Solutions
2.18.4 BioRestorative Therapies Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.18.5 BioRestorative Therapies Recent Developments and Future Plans
2.19 bluebird bio
2.19.1 bluebird bio Details
2.19.2 bluebird bio Major Business
2.19.3 bluebird bio Targeted Drug Delivery Device Product and Solutions
2.19.4 bluebird bio Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.19.5 bluebird bio Recent Developments and Future Plans
2.20 Boston Scientific
2.20.1 Boston Scientific Details
2.20.2 Boston Scientific Major Business
2.20.3 Boston Scientific Targeted Drug Delivery Device Product and Solutions
2.20.4 Boston Scientific Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.20.5 Boston Scientific Recent Developments and Future Plans
2.21 CellProthera
2.21.1 CellProthera Details
2.21.2 CellProthera Major Business
2.21.3 CellProthera Targeted Drug Delivery Device Product and Solutions
2.21.4 CellProthera Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.21.5 CellProthera Recent Developments and Future Plans
2.22 Celsion
2.22.1 Celsion Details
2.22.2 Celsion Major Business
2.22.3 Celsion Targeted Drug Delivery Device Product and Solutions
2.22.4 Celsion Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.22.5 Celsion Recent Developments and Future Plans
2.23 Celyad
2.23.1 Celyad Details
2.23.2 Celyad Major Business
2.23.3 Celyad Targeted Drug Delivery Device Product and Solutions
2.23.4 Celyad Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.23.5 Celyad Recent Developments and Future Plans
2.24 Evonik
2.24.1 Evonik Details
2.24.2 Evonik Major Business
2.24.3 Evonik Targeted Drug Delivery Device Product and Solutions
2.24.4 Evonik Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.24.5 Evonik Recent Developments and Future Plans
2.25 Kadimastem
2.25.1 Kadimastem Details
2.25.2 Kadimastem Major Business
2.25.3 Kadimastem Targeted Drug Delivery Device Product and Solutions
2.25.4 Kadimastem Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.25.5 Kadimastem Recent Developments and Future Plans
2.26 Medtronic
2.26.1 Medtronic Details
2.26.2 Medtronic Major Business
2.26.3 Medtronic Targeted Drug Delivery Device Product and Solutions
2.26.4 Medtronic Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.26.5 Medtronic Recent Developments and Future Plans
2.27 Novartis
2.27.1 Novartis Details
2.27.2 Novartis Major Business
2.27.3 Novartis Targeted Drug Delivery Device Product and Solutions
2.27.4 Novartis Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.27.5 Novartis Recent Developments and Future Plans
2.28 Sanofi
2.28.1 Sanofi Details
2.28.2 Sanofi Major Business
2.28.3 Sanofi Targeted Drug Delivery Device Product and Solutions
2.28.4 Sanofi Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.28.5 Sanofi Recent Developments and Future Plans
2.29 SOTIO
2.29.1 SOTIO Details
2.29.2 SOTIO Major Business
2.29.3 SOTIO Targeted Drug Delivery Device Product and Solutions
2.29.4 SOTIO Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.29.5 SOTIO Recent Developments and Future Plans
2.30 Takeda
2.30.1 Takeda Details
2.30.2 Takeda Major Business
2.30.3 Takeda Targeted Drug Delivery Device Product and Solutions
2.30.4 Takeda Targeted Drug Delivery Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.30.5 Takeda Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Targeted Drug Delivery Device Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Targeted Drug Delivery Device by Company Revenue
3.2.2 Top 3 Targeted Drug Delivery Device Players 麻豆原创 Share in 2023
3.2.3 Top 6 Targeted Drug Delivery Device Players 麻豆原创 Share in 2023
3.3 Targeted Drug Delivery Device 麻豆原创: Overall Company Footprint Analysis
3.3.1 Targeted Drug Delivery Device 麻豆原创: Region Footprint
3.3.2 Targeted Drug Delivery Device 麻豆原创: Company Product Type Footprint
3.3.3 Targeted Drug Delivery Device 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Targeted Drug Delivery Device Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Targeted Drug Delivery Device 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Targeted Drug Delivery Device Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Targeted Drug Delivery Device 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Targeted Drug Delivery Device Consumption Value by Type (2019-2030)
6.2 North America Targeted Drug Delivery Device Consumption Value by Application (2019-2030)
6.3 North America Targeted Drug Delivery Device 麻豆原创 Size by Country
6.3.1 North America Targeted Drug Delivery Device Consumption Value by Country (2019-2030)
6.3.2 United States Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Targeted Drug Delivery Device Consumption Value by Type (2019-2030)
7.2 Europe Targeted Drug Delivery Device Consumption Value by Application (2019-2030)
7.3 Europe Targeted Drug Delivery Device 麻豆原创 Size by Country
7.3.1 Europe Targeted Drug Delivery Device Consumption Value by Country (2019-2030)
7.3.2 Germany Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Targeted Drug Delivery Device Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Targeted Drug Delivery Device Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Targeted Drug Delivery Device 麻豆原创 Size by Region
8.3.1 Asia-Pacific Targeted Drug Delivery Device Consumption Value by Region (2019-2030)
8.3.2 China Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Targeted Drug Delivery Device Consumption Value by Type (2019-2030)
9.2 South America Targeted Drug Delivery Device Consumption Value by Application (2019-2030)
9.3 South America Targeted Drug Delivery Device 麻豆原创 Size by Country
9.3.1 South America Targeted Drug Delivery Device Consumption Value by Country (2019-2030)
9.3.2 Brazil Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Targeted Drug Delivery Device Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Targeted Drug Delivery Device Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Targeted Drug Delivery Device 麻豆原创 Size by Country
10.3.1 Middle East & Africa Targeted Drug Delivery Device Consumption Value by Country (2019-2030)
10.3.2 Turkey Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Targeted Drug Delivery Device 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Targeted Drug Delivery Device 麻豆原创 Drivers
11.2 Targeted Drug Delivery Device 麻豆原创 Restraints
11.3 Targeted Drug Delivery Device Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Targeted Drug Delivery Device Industry Chain
12.2 Targeted Drug Delivery Device Upstream Analysis
12.3 Targeted Drug Delivery Device Midstream Analysis
12.4 Targeted Drug Delivery Device Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
4D Molecular Therapeutics
AbbVie
Abeona Therapeutics
Advaxis
Alcyone Lifesciences
AlphaVax
Amgen
Amicus Therapeutics
Anaeropharma Science
AnGes
AskBio
Astellas Pharma
AstraZeneca
Athersys
BioCardia
Biogen
BioInvent
BioRestorative Therapies
bluebird bio
Boston Scientific
CellProthera
Celsion
Celyad
Evonik
Kadimastem
Medtronic
Novartis
Sanofi
SOTIO
Takeda
听
听
*If Applicable.
